Showing results (51-60 of 696) with videos related to
Sort By:
Pageof 70
Blood|August 1, 2009
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trialThorsten Zenz, Sonja Häbe, Tina Denzel, et al.Hematology. American Society of Hematology. Education Program|January 18, 2011
Understanding and managing ultra high-risk chronic lymphocytic leukemiaStephan Stilgenbauer, Thorsten ZenzJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemiaAlexander Kröber, Johannes Bloehdorn, Sebastian Hafner, et al.International Journal of Cancer|October 12, 2005
Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancerStephan Wolf, Daniel Mertens, Armin Pscherer, et al.Haematologica|December 3, 2009
Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemiaDirk Kienle, Axel Benner, Carolin Läufle, et al.Blood|November 9, 2023
How I treat refractory and relapsed acute myeloid leukemiaFelicitas Thol, Hartmut Döhner, Arnold GanserJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implicationsGuido Marcucci, Torsten Haferlach, Hartmut DöhnerJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Genomics of Acute Myeloid Leukemia Diagnosis and PathwaysLars Bullinger, Konstanze Döhner, Hartmut DöhnerHaematologica|December 6, 2006
Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigensJochen Greiner, Hartmut Döhner, Michael SchmittCurrent Oncology Reports|February 7, 2020
Revolution of Chronic Lymphocytic Leukemia Therapy: the Chemo-Free Treatment ParadigmAnnika Scheffold, Stephan StilgenbauerPageof 70